Automated external beam radiation therapy adapted to internal dose
By generating reference and conversational patient models, using internal dose measurement data to automate adaptive workflows, the problem of incorporation of dosage measurement data in external beam radiation therapy is solved, the accuracy and safety of treatment is improved, and dual-modal radiation is achieved Seamless integration of protocols.
Patent Information
- Application Number
- CN202410563491.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-08
- Filing Date
- 2024-05-08
- Publication Date
- 2024-11-08
AI Technical Summary
The existing external beam radiation therapy and internal radiation therapy lack a unified framework in the correlation between dosage determination and biological effects, making it difficult to seamlessly incorporate the dosage determination data of internal radiation treatment into external beam radiation therapy, affecting the therapeutic effect and safety. sex.
By generating reference patient models and conversational patient models, the adaptive workflow is automated using internal dose determination data, and external beam radiation therapy plans are adjusted to adapt to changes in the anatomy, achieving seamless integration of the dual-modal radiation protocol.
Improve the accuracy and safety of external beam radiation therapy, ensure the effective delivery of target doses and the protection of surrounding tissues, and enhance the therapeutic effect.
Smart Images

Figure CN118903702A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates generally to dual-modality radiation therapy treatment protocols, and more particularly to systems, methods, and apparatus for automated external beam radiation therapy adapted to internal doses. The present disclosure also relates to systems, methods, and apparatus for incorporating dosimetry data obtained in internal radiation therapy to guide an automated adaptive workflow for external beam radiation therapy. Background Art
[0002] External radiation beam therapy (ERBT) involves a medical procedure that uses an external radiation beam to treat pathological anatomy (tumors, lesions, vascular malformations, neurological disorders, etc.) by delivering a specified dose of radiation (X-rays, gamma rays, electrons, protons and / or ions) to the pathological anatomy while minimizing radiation exposure to surrounding tissues and critical anatomical structures.
[0003] Typically, (EBRT) treatment consists of several stages. First, use any one (or combination thereof) of computed tomography (CT), cone beam computed tomography (CBCT), magnetic resonance imaging (MRI), positron emission tomography (PET), 3D rotational angiography (3DRA) or ultrasound technology to construct an accurate three-dimensional (3D) map of the anatomical structure in the region of interest (head, body, etc.). This determines the exact coordinates of the target within the anatomical structure, that is, locates the tumor or abnormality in the body and defines its exact shape and size. Secondly, taking into account various medical constraints, the motion path of the radiation beam is calculated to deliver the radiation oncologist to find an acceptable dose distribution. During this stage, a team of experts uses special computer software to develop a treatment plan to optimally irradiate the tumor and minimize the dose to surrounding normal tissues by designing a beam of radiation that converges on the target area from different angles and planes. Third, the radiation treatment plan is executed. During this stage, the radiation dose is delivered to the patient according to the specified treatment plan. Typically, the treatment plan is delivered to the patient through a series of radiation treatments called fractions.
[0004] There are many factors that can contribute to the difference between the specified radiation dose distribution and the actual dose delivered (i.e., the actual dose delivered to the target during radiation treatment). One such factor is the uncertainty in the position of the patient in the radiation therapy system. Other factors involve uncertainties introduced by changes that may occur during the patient's treatment. Such changes can include random errors, such as small differences in the patient's set position. Other sources are attributable to physiological changes that may occur if the patient's tumor regresses or if the patient loses weight during treatment. Another category of uncertainty includes motion. Since some motion may be more random and unpredictable, while other motion may be more regular, motion may potentially overlap with any of the categories.
[0005] These anatomical and physiological changes may cause the target volume (i.e., the target to be irradiated) and the surrounding anatomical structures and organs to move and change size and shape during treatment. Therefore, continuing to follow the initial treatment plan may result in the actual received dose distribution being different from the planned distribution and thus leading to a dose reduction to the target volume and / or a dose increase to organs at risk (OARs), which may ultimately lead to adverse patient outcomes. Adapting the treatment plan (i.e., modifying the initial treatment plan based on subsequently acquired image data to match the new position and shape of the target volume and surrounding anatomical structures) is one way to correct this problem.
[0006] Adaptive radiation therapy is a process by which, using subsequent images, the original treatment plan can be adjusted to offset these anatomical changes. The adaptive radiation therapy process is a closed-loop radiation treatment process in which measured system feedback can be used to modify the treatment plan. Adaptive radiation therapy improves radiation treatment by systematically monitoring treatment changes and by incorporating them to re-optimize the treatment plan during the course of treatment.
[0007] Adaptive radiation therapy can occur on three different time scales, namely, offline between treatment fractions, online immediately before a treatment fraction, and in real time during a treatment fraction.
[0008] During offline adaptive therapy, new images (e.g., CT or CTBC images) of the patient are acquired during each treatment fraction, before or after each fraction, and the images are evaluated to determine the multi-day position of the target volume. Based on this, a new plan can be developed to better reflect the range of motion of the target volume.
[0009] During online (on-couch) real-time adaptive therapy, the radiation therapy system may be used prior to fractionation to confirm or adjust the patient treatment plan for treatment delivery. Thus, the imaging system may be used to concurrently modify treatment delivery to reflect changes in the patient's anatomy.
[0010] The radiation therapy system can also be used during treatment fractions during couch-based adaptive therapy.Couch-based adaptive radiation therapy allows the treatment plan to be adjusted based on the tumor and anatomical changes while the patient is on the treatment table.
[0011] Couch-based adaptive radiation therapy can also allow the delivered dose to be recalculated after each fraction and these doses to be accumulated during accumulation using image and dose deformation techniques to account for internal motion. The calculated dose can then be compared to the initially planned dose and if any gaps are noted, subsequent fractions can be modified to account for these changes.
[0012] Internal radiation therapy is a medical procedure that uses internal radiation beams to treat pathological anatomy by delivering radiation using radioactive isotopes linked to specific molecules, such as radiopharmaceuticals or radiotracers. Radiopharmaceuticals are used to target diseased tissues by means of specific chemical and / or biological affinity, using radiation applied at the cellular level. Radiopharmaceuticals can be injected intravenously or by intra-arterial or oral routes, and can reach the tumor site through molecular radiation therapy (MRT) or selective intra-arterial radiation therapy (SIRT). MRT uses the natural tropism of radionuclides or carrier molecules selected according to the biochemical properties of the disease, so that the radiopharmaceutical preferentially binds to target cells. On the other hand, SIRT takes advantage of tumor vascularization. In SIRT, the radiopharmaceutical is injected directly into the tumor arterial blood circulation in the form of microspheres and no active molecules are required.
[0013] The imaging or therapeutic capabilities of each radioisotope are determined by the type of radiation emitted. For example, low linear energy transfer (LET) radioisotopes that emit electromagnetic radiation (i.e., 18F fluorodeoxyglucose (FDG), which emits gamma rays during positron decay) can be used for imaging because the electromagnetic radiation can be detected by imaging systems (PET, single photon emission computed tomography (SPECT), CT, etc.), and high LET radioisotopes that emit particle radiation (i.e., alpha / beta particles) can be used for therapy because they have cytotoxic (i.e., therapeutic) properties.
[0014] Some radioisotopes (e.g., Lutetium-177) can emit both electromagnetic and particle radiation, allowing for simultaneous treatment and imaging. Diagnostic and therapeutic radiopharmaceuticals that access the same cellular structures and biological processes (i.e., they share the same target) are considered theranostic pairs, where "theranostic" is the coupling of diagnostic and therapeutic tools associated with the same molecular target.
[0015] The measure for evaluating the efficacy and toxicity of internal radiation treatment is the absorbed dose, as it is a physical quantity that evaluates the damage to targeted cells and normal organs by the emitted radiation.
[0016] Internal radiation therapy is administered either: by a fixed activity, where all patients receive the same administered dose; by a maximum tolerated dose, where patients receive an individualized administered activity predicted to deliver the maximum tolerated absorbed dose to normal tissue; or by a specified tumor absorbed dose, where patients receive an individualized administered activity predicted to deliver a specified therapeutic absorbed dose to tumor or target tissue. Patient-specific and specified tumor dose methods typically require a series of pre-treatment measurements to derive an administered activity that delivers the correct dose. After treatment, post-treatment dosimetry is performed to verify the delivered absorbed dose.
[0017] Therefore, internal radiation therapy and external beam radiation therapy are radiation treatment modalities that cause different biological effects in patients due to their dissimilar modes of administration, dose rates, dose distributions, and molecular mechanisms of cytotoxicity. EBRT is generally used to resect dominant tumors, while internal radiation therapy is used to control dominant tumors while eradicating smaller extensive deposits.
[0018] Despite the recognition that combining these two radiation treatment modalities would be beneficial to the patient, a dosimetric framework is currently lacking that relates the amount and spatio-temporal pattern of energy deposited by each treatment modality to the total biological effect of the two together.
[0019] Therefore, there is a need to provide a framework by which dosimetry data from internal radiation treatments can be incorporated into treatment planning, treatment adaptation, and safe treatment delivery for external beam radiation therapy. Summary of the invention
[0020] Embodiments of the disclosed subject matter enable seamless implementation of dosimetry data obtained from an internal radiation treatment protocol (ie, internal dosimetry data) into an external beam radiation treatment protocol.
[0021] Embodiments of the disclosed subject matter also enable the use of internal dosimetry data in the planning of treatment for external beam radiation treatment protocols.
[0022] Embodiments of the disclosed subject matter also provide a framework that allows in-house dosimetry data to be incorporated into the automated workflow of adaptive radiation treatment protocols.
[0023] Embodiments of the disclosed subject matter also provide an automated adaptive workflow to adapt the treatment plan generated using internal dosimetry data to the patient's anatomy at each fraction, while the patient is on the treatment couch.
[0024] In a disclosed embodiment, a radiation treatment method includes sequentially exposing a patient to a dual-modality radiation protocol, the dual-modality radiation protocol including an internal radiation protocol and an external beam radiation protocol, the internal radiation protocol including administering a radiopharmaceutical to the patient; and generating a dosimetry image of the distribution of radiopharmaceutical activity in the patient; and the external beam radiation protocol including implementing an automated workflow to generate a radiation treatment plan based on dosimetry image data; adapt the radiation treatment plan to a current treatment session; and deliver the adapted treatment plan to the patient.
[0025] An internal radiation protocol is a protocol that may include one of: radiological systemic therapy, radioembolization radiation treatment, radiolabeled chemotherapy, radiolabeled immunotherapy, or radiolabeled targeted radiation therapy.
[0026] The external beam radiation protocol may be a couch-based adaptive radiation therapy protocol and the automated workflow is an automated adaptive workflow.
[0027] In a disclosed embodiment, a method for generating a radiation treatment plan includes: generating a reference patient model using internal dosimetry images; and selecting a set of planned clinical objectives for the reference patient model as input to a plan generation and optimization algorithm, wherein the plan generation and optimization algorithm derives objectives for the planned clinical objectives and generates a reference treatment plan that meets the derived objectives.
[0028] In a disclosed embodiment, a method of adapting a radiation treatment plan to a current treatment session includes performing a series of automated steps using a set of instructions to: generate a treatment session patient model; generate a first treatment plan and a second treatment plan for the session patient model; and select a treatment plan suitable for the current treatment session.
[0029] An embodiment also includes a method for generating a treatment plan for external beam radiation therapy, the method comprising: obtaining an internal dosimetry map indicating radiopharmaceutical uptake in a patient's body derived from a SPECT / CT or PET / CT image from an internal radiation treatment system; automatically converting the radiopharmaceutical uptake into targets to be irradiated and targets to be avoided; applying an automated contouring process to generate a target structure on a reference image, the target structure representing the contours of the targets to be irradiated and the contours of the targets to be avoided, the reference image being a CT image used to obtain the dosimetry SPECT / CT or PET / CT image; and selecting a set of planned clinical objectives for the target structure as input to a plan generation and optimization algorithm to automatically derive objectives for the planned clinical objectives and generate a reference treatment plan that meets the derived objectives.
[0030] An embodiment also includes a system for implementing an automated workflow for an adaptive radiation therapy session for a patient, the system comprising: a computer processing system configured to: obtain an indication set comprising information representing a planned treatment plan for the patient; and using the indication set, perform a series of automated steps to: generate a session patient model; and generate an adapted treatment plan for the session patient model, wherein the planned treatment plan is generated based on dosimetry SPECT / CT or PET / CT derived image data indicating radiopharmaceutical uptake in the patient.
[0031] Also disclosed is an adaptive therapy workflow for generating a session patient model and selecting a treatment plan for a treatment session, the workflow comprising: obtaining an indication set including information related to a planned treatment for a patient; using the indication set to guide the adaptive workflow to generate a session patient model in a step-by-step manner starting from a most variable anatomy; using indications from the indication set to continuously and automatically optimize the treatment plan generated for the session model to obtain an adapted plan for the treatment session; using the generated session model to automatically transfer control points of the planned treatment to generate a plan for scheduling the treatment session; and using indications from the indication set to allow a user to select a treatment plan suitable for the treatment session.
[0032] Also disclosed is an adaptive therapy workflow for generating an adapted treatment plan for a session patient model that does not require generation of synthetic image data of the patient.
[0033] Also disclosed is a system configured to perform the method steps as disclosed herein.
[0034] Also disclosed is a system comprising a computer processing device configured to execute a sequence of programming instructions embodied on a computer-readable storage medium, the execution of which causes the system to perform the method steps disclosed herein.
[0035] Also disclosed is a non-transitory computer-readable storage medium having a sequence of programming instructions embodied thereon for generating a reference treatment plan based on internal dosimetry information from an internal radiation protocol and for generating daily treatment images to be used in adaptive radiation therapy, and a computer processing system that executes the sequence of programming instructions embodied on the computer-readable storage medium. Execution of the sequence of programming instructions may cause the computer processing system to perform the adaptive workflow described herein.
[0036] Objects and advantages of embodiments of the disclosed subject matter will become apparent from the following description when considered in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1A and Figure 1B is a simplified schematic diagram of an external beam radiation therapy system in accordance with various embodiments of the disclosed subject matter.
[0038] Figure 2 According to various embodiments of the disclosed subject matter Figure 1A and Figure 1B Simplified illustration of an external beam radiation therapy system used for couch-based adaptive radiation therapy.
[0039] Figure 3 is a workflow diagram for use in couch-based adaptive radiation therapy according to various embodiments of the disclosed subject matter.
[0040] Figures 4 to 5 is a process flow diagram for generating internal dosimetry images / data in an internal radiation protocol in accordance with various embodiments of the disclosed subject matter.
[0041] Figure 6 to Figure 7 is an illustration of a process flow for generating a reference patient model in accordance with various embodiments of the disclosed subject matter.
[0042] Figure 8 is a process flow diagram for generating a reference treatment plan in accordance with various embodiments of the disclosed subject matter.
[0043] Figures 9 and 10 is an illustration of a clinical goal template available to a user in accordance with various embodiments of the disclosed subject matter.
[0044] Figures 11 to 14 is a process flow diagram of session patient model generation in accordance with various embodiments of the disclosed subject matter.
[0045] Fig.15 is a process flow diagram for generating different treatment plans for a session patient model in accordance with various embodiments of the disclosed subject matter.
[0046] Fig.16 is a process flow diagram for determining a treatment isocenter in accordance with various embodiments of the disclosed subject matter.
[0047] Fig.17 is a process flow diagram for selecting and delivering a treatment plan and determining additional treatments in accordance with various embodiments of the disclosed subject matter.
[0048] Figure 18 to Figure 19 Screen shot illustrating the display of the treatment plan, treatment dose, and treatment isodose verification process. DETAILED DESCRIPTION
[0049] refer to Figure 1Aand Figure 1B , shows an exemplary external beam radiation therapy (EBRT) system 100, which is configured to be used in Figure 2 The adaptive external radiation beam protocol shown in FIG. 1 is used in the adaptive external radiation beam protocol shown in FIG. The (EBRT) system 100 can provide radiation to a patient 110 located on a treatment couch 112 and can allow for various radiation dose verification protocols to be implemented. The radiation therapy can include photon-based radiation therapy, particle therapy, electron beam therapy, or any other type of treatment therapy.
[0050] In one embodiment, the (EBRT) system 100 may include a radiation treatment device 101, such as but not limited to a LINAC, which is operable to generate one or more beams of megavoltage (MV) X-ray radiation for treatment. The LINAC may also be operable to generate one or more beams of kilovoltage (kV) X-ray radiation, for example, for patient imaging. The (EBRT) system 100 has a gantry 102 supporting a radiation treatment head 114, which has one or more radiation sources 106 and various beam modulation elements, such as but not limited to a flattening filter 104 and a collimating component 108. The collimating component 108 may include, for example, a multi-leaf collimator (MLC), an upper and lower jaw, and / or other collimating elements. The collimating component 108 and / or the flattening filter 104 may be positioned within the radiation beam path by a corresponding actuator (not shown), which may be controlled by a controller 116.
[0051] The gantry 102 can be an annular gantry (i.e., it extends through a full 360° arc to create a complete ring or circle), but other types of mounting arrangements can also be used. For example, a static beam, or a C-shaped partial annular gantry, or a robotic arm can be used. Any other framework capable of positioning the treatment head 114 at various rotational and / or axial positions relative to the patient 110 can also be used.
[0052] In one embodiment, the radiation therapy device 101 is a MV energy intensity modulated radiation therapy (IMRT) device. The intensity distribution in such a system is customized according to the treatment requirements of individual patients. The IMRT field is delivered using MLC 108, which can be a computer-controlled mechanical beam shaping device attached to the head 114 and includes an assembly of metal fingers or leaves. For each beam direction, an optimized intensity distribution is achieved by sequential delivery of various subfields with optimized shapes and weights. From one subfield to the next, the leaves can move as the radiation beam is turned on (i.e., dynamic multi-leaf collimation (DMLC)) or as the radiation beam is turned off (i.e., segmented multi-leaf collimation (SMLC)).
[0053] Alternatively or additionally, the radiation therapy device 101 can be a tomotherapy device in which intensity modulation is achieved using a binary collimator (not shown) that is opened and closed under computer control (e.g., control 116). When the gantry 102 rotates continuously around the patient 110, the exposure time of the small width beam can be adjusted by opening and closing the binary collimator, allowing the radiation 120 to be directed to a portion of the body of the patient 110 and delivered to the region of interest 122 through the most desired direction and position of the patient 110. The region of interest is a two-dimensional area and / or three-dimensional volume that is expected to receive radiation, and it can be referred to as a target or target area or target volume. Another type of region of interest is a region at risk. If the portion includes the region at risk, the radiation bypasses the region at risk. The patient 110 may have more than one target area that needs to receive radiation therapy.
[0054] Alternatively or additionally, the radiation therapy device can be a volumetric modulated arc therapy (VMAT) device. In fact, any type of IMRT device can be used as the radiation therapy device 101 of the EBRT system 100, and can also include on-board volume imaging, which can be used to generate on-treatment image data generated during the treatment session.
[0055] For example, embodiments of the disclosed subject matter can be applied to image-guided radiation therapy (IGRT) devices that use cross-sectional images of the patient's internal anatomy acquired during a radiation therapy treatment session (i.e., in-treatment images) to provide information about the patient's position. Frequent two-dimensional or three-dimensional imaging during radiation treatment is used to guide the treatment radiation using imaging coordinates of the actual radiation treatment plan. This ensures that the patient is positioned in the radiation treatment system at the same location as planned, and ensures that the patient is properly aligned during treatment. Although the IGRT process involves conformal radiation treatment guided by specialized imaging tests acquired during the planning phase, it does rely on imaging modalities from the planning process as reference coordinates for positioning the patient 110 during treatment. Therefore, associated with each image-guided radiation therapy system is an imaging system for providing in-treatment (treatment session) images, which are used to set up the radiation delivery process.
[0056] The on-treatment images may include one or more two-dimensional or three-dimensional images (typically X-rays) acquired at one or more different points during treatment. There are a variety of ways to acquire on-treatment images. In some methods, different independent imaging systems and / or imaging methods are used to acquire pre-treatment images and on-treatment images, respectively. For example, 3D IGRT may include positioning of a cone beam computed tomography (CBCT) dataset using a planning computed tomography (CT) dataset, and 2D IGRT may include matching planar kilovoltage (kV) radiographs or megavoltage (MV) images with digitally reconstructed radiographs (DRRs) obtained from the planning CT.
[0057] Another approach is to use a portal imaging system. In a portal imaging system, a detector is placed opposite the source of therapeutic radiation to image the patient for both setup and intra-treatment imaging. Another approach is tomosynthesis, which is an intra-treatment imaging modality used in conjunction with a radiation treatment system.
[0058] Alternatively, the (EBRT) system 100 may include a kilovoltage or megavoltage detector operable to receive the radiation beam 120. The radiation therapy device 101 and the detector may operate as a computed tomography (CT) system to generate CT images of the patient. The images may illustrate the patient's body tissues, organs, bones, soft tissues, blood vessels, etc.
[0059] Each type of radiation therapy device may be accompanied by a corresponding radiation plan and radiation delivery procedure.
[0060] like Figure 1B As shown in , the controller 200, which may be, but is not limited to, a graphics processing unit (GPU), may include a computer having suitable hardware such as a processor, and an operating system for running various software programs and / or communication applications. The controller 200 may include software programs that operate to communicate with the radiation therapy device 101, which are operable to receive data from external software programs and hardware. The computer may also include any suitable input / output (I / O) device 210, which may be suitable for allowing communication between the controller 200 and a user (e.g., medical personnel) of the (EBRT) system 100. For example, the controller 200 may be provided with an I / O interface, a console, a storage device, a memory, a keyboard, a mouse, a monitor, a printer, a scanner, and a department information system (DIS), such as a communication and management interface (DICOM) for storing and transmitting medical imaging information and related data and enabling integration of medical imaging devices (such as scanners, servers, workstations, printers, network hardware, etc.).
[0061] Alternatively or additionally, the I / O device 210 may provide access to a network (not shown) for transmitting data between the controller 200 and remote systems. For example, the controller 200 may be networked with other computers and radiation therapy systems including the internal radiation delivery system 300 via the I / O 210 for, for example, receiving dosimetry images and dosimetry image data 310 from the internal radiation delivery system 300. The EBRT system 100, the radiation treatment device 101, and the controller 200 may communicate with the network as well as databases and servers, such as a dose calculation server (e.g., a distributed dose calculation framework) and a treatment planning system 400. The controller 200 may also be configured to transfer medical image-related data between different medical equipment.
[0062] The EBRT system 100 may also include multiple modules, including an automated workflow module 220 (e.g., as part of the controller 200, or as a separate module within the EBRT system 100, or integrated into other components of the EBRT system 100), which contains programming instructions that, when executed, cause the EBRT system 100 to perform various functions related to adaptive radiation therapy or other radiation treatments, as discussed herein. For example, the EBRT system 100 may include: a treatment plan generation module 400B, which is operable to generate a treatment plan for the patient 110 based on multiple data input into the EBRT system 100 by medical personnel; a patient positioning module, which is operable to position and align the patient 110 relative to a desired position (such as the isocenter of the gantry) for a specific radiation therapy treatment; an image acquisition module, which is operable to instruct the EBRT system 100 and / or the imaging device 101 to acquire images of the patient 110 before the radiation therapy treatment (i.e., anatomical images for treatment planning and patient positioning) and / or to acquire images of the patient 110 during the radiation therapy treatment (i.e., treatment session images), and to instruct the EBRT system 100 and / or the imaging device 101 or other imaging devices or systems to acquire images of the patient 110.
[0063] The EBRT system 100 may also include: a dose calculation module, which is operable to calculate the actual dose delivered to the patient 110 during the radiation therapy treatment; a treatment delivery module, which is operable to instruct the radiation therapy device 100 to deliver the treatment plan to the patient 110; a correlation module, which is operable to correlate the planning image with the treatment image obtained during the radiation therapy; a calculation module, which is operable to reconstruct a three-dimensional target volume from the treatment image; an analysis module, which is operable to calculate displacement measurements; and a feedback module, which is operable to instruct the controller in real time to stop the radiation therapy based on a comparison of the calculated displacement with a predetermined threshold (range).
[0064] The EBRT system 100 may also include: one or more contour generation modules, which are operable to generate contours of target volumes and other structures in pre-treatment (planning, reference) and treatment (treatment session) images; an image registration module, which is operable to register pre-treatment images with subsequent treatment images; a dose calculation module, which is operable to calculate cumulative doses; a contour propagation module, which is operable to propagate contours from one image to another; a contour verification module, which is operable to verify the generated contours; a registration deformation vector field generation module, which is operable to determine the deformation vector field (DVF) as a result of the image deformation process. The EBRT system 100 may also include modules for: electron density map generation, isodose distribution generation, dose volume histogram (DVH) generation, image synchronization, image display, treatment plan generation, treatment plan optimization, automatic optimization parameter generation, update and selection, and adaptive indication and treatment information transfer. For example, these modules can be written in C or C++ programming languages. Computer program code for performing operations as described herein can be written in any programming language, such as C or C++ programming languages.
[0065] Figure 3 FIG. 1 illustrates an automated workflow S100 implemented via the module 220 of the EBRT system 100 to seamlessly integrate the internal radiation treatment dosimetry data 310 into the ( Figure 2 In the adaptive radiation treatment protocol on the couch (as shown in ).
[0066] The internal dosimetry images / data 310 are obtained from the internal radiation treatment protocol implemented in the internal radiation delivery system 300 via the I / O 210. The internal dosimetry images / data 310 are made available to the EBRT system 100 via the I / O 200 or DICOM or imaging console. The internal dosimetry images / data 310 may also be generated by different independent imaging systems and / or imaging methods and / or imaging / image generation software and transmitted to the EBRT system 100 via the I / O 200 connection to other networks, databases and servers that allow the realization and transfer of medical images / medical image data.
[0067] The internal radiation treatment protocol may be a treatment protocol for any of: radiological systemic therapy, radioembolization radiation treatment, radiolabeled chemotherapy, radiolabeled immunotherapy, and radiolabeled targeted radiation therapy.
[0068] exist Figure 4 In the exemplary internal radiation protocol S300 shown in FIG. 1 , a radiopharmaceutical is administered to a patient 110 ( S301 ). Different radiopharmaceuticals may be used, depending on the disease to be treated and the type of therapeutic application. For example, 131 I can be used to treat thyroid disease or cancer, (131 )mIBG is used to treat neuroblastoma. 90 Y-DOTATOC is used for PRRT in the treatment of NET and other tumors expressing somatostatin receptors. 90 Y resin or glass microspheres or 166 Ho ply-L-lactic acid microspheres for radioembolization of primary and secondary liver tumors. 90 Y-MoAbs are used for radioimmunotherapy of hematological malignancies (leukemia, MDS, myeloma, lymphoma). 177 Lu-PSMA is used to treat prostate cancer. 223 Ra is used for bone metastases from breast cancer and prostate cancer, etc. This list is not exhaustive. It should be understood that the dual-modality radiation protocol described herein is applicable to any internal radiation protocol / treatment / treatment that currently exists or will be developed using radiopharmaceuticals that currently exist or will be developed in the future, including but not limited to radiotherapy protocols, radioembolization radiation treatment protocols, radiolabeled chemotherapy protocols, radiolabeled immunotherapy protocols, and any other radiolabeled targeted therapy protocols.
[0069] Next, dosimetry is performed in S302 to assess the distribution of radiopharmaceutical activity within the patient's body.Depending on the radiopharmaceutical, the number of treatment cycles, and the type of radiation treatment, dosimetry may be performed at different times within the radiation protocol.
[0070] In cases where the radiopharmaceutical itself presents an emission channel or a paramagnetic component that can be used to track the substance using imaging systems (planar scintigraphy, SPECT, PET, MRI, etc.), treatment usually consists of a single administration and dosimetry is usually performed prior to treatment (i.e. at the diagnostic stage) by administering a tracer activity (i.e. a small amount of the radiopharmaceutical).
[0071] In case multiple cycles are planned and the radiopharmaceutical is suitable for imaging, dosimetry can be performed during treatment, in the first and / or subsequent cycles.
[0072] In cases where a radiopharmaceutical is not suitable for imaging, an alternative radiopharmaceutical may be used for dosimetry. The alternative radiopharmaceutical has a physical half-life that is compatible with the biological half-life of the carrier and has similar chemical properties.
[0073] Dosimetry may also be performed after treatment (ie, post-treatment dosimetry).
[0074] Typically, dosimetry in an internal radiation treatment protocol involves a calibration step, a patient image acquisition step, a reconstruction / correction step, a registration and correction step, a cumulative activity step, and an absorbed dose calculation step.
[0075] The calibration and imaging steps are interconnected and include the preparation of the appropriate radiopharmaceutical and the selection and application of the appropriate imaging method. Based on the treatment, planar, hybrid and 3D dosimetry protocols can be adopted. In the planar protocol, sequential whole-body 2D images are acquired, which enables the calculation of the average absorbed dose of the organ or lesion. In order to be able to determine the absorbed dose at the voxel level, that is, to obtain a dose map, an additional SPECT / CT or PET / CT image can be acquired at one of the time points to assess the activity, and then combined with the activity changes over time derived from the series of planar images (i.e., hybrid protocol). As another option, multiple SPECT / CT or PET / CT (i.e., 3D protocol) can be used for complete 3D information.
[0076] The reconstruction / correction step derives the activity in the pixels / voxels that make up the image from the raw acquisition (counts) from the image. An activity image can be derived at the end of this step by applying calibration factors.
[0077] By segmenting and registering the images acquired at different time points, the registration and correction steps allow for the estimation of activity in a region or volume of interest. This can result in the quantification of activity present in the patient in various organs / regions / tissues of interest or at the voxel level at different time points.
[0078] Thus, the cumulative activity (ie, time-integrated activity) can be derived using different extrapolation methods, such as the time-integrated activity (TIA) or time-integrated activity coefficient (TIAC) methods.
[0079] The absorbed dose calculation step can be performed in different ways, such as by using pre-calculated values (S values from specific absorption fraction estimates) or by implementing different absorbed dose calculation algorithms. Thus, absorbed dose, absorbed dose maps and absorbed dose-volume histograms can be obtained.
[0080] The internal dosimetry image / data 310 that can be used in process S100 can be any dosimetry image / data generated by the dosimetry process S300 for a specific internal radiation treatment protocol, including dosimetry data obtained during the diagnostic, therapeutic, or post-treatment phases of the internal radiation treatment. In S304, the internal dosimetry image 310 and associated dosimetry data are made available to the I / O 210 of the EBRT system 100.
[0081] Figure 5An exemplary internal radiation treatment dosimetry process S400 is illustrated, wherein after administration of a radiopharmaceutical to a patient S401, one of planar, hybrid, or 3D imaging protocols is applied (S402) to generate a series of raw images indicating activity inside each of the source regions. In the case of SPECT or PET imaging, the raw data acquired in the projections is reconstructed in S403. By calibrating the SPECT / PET reconstructed images via calibration factors, an internal dosimetry image 310A (radiopharmaceutical activity image) can be obtained. The internal dosimetry image 310A shows areas in the patient where radiopharmaceutical activity is present.
[0082] By superimposing the reconstructed SPECT / PET image on the patient's anatomy obtained from the CT image (S404), the activity in the region or volume of interest can be estimated. By applying an integration algorithm S405 to the estimated activity, the cumulative activity (tumor uptake pattern) in the region or volume of interest can be obtained, based on which the absorbed dose in each region or volume of interest can be calculated. The cumulative activity can be converted into a dose map 310B in S406. The dose map quantitatively shows the radiopharmaceutical distribution activity / dose uptake pattern of the tumor / diseased area.
[0083] To be in Figure 3 The internal dosimetry image / data 310 used in the EBRT adaptive process S100 may be any one of the internal dosimetry image / data 310A, 310B, 310C. The internal dosimetry image data 310 may also be dosimetry data obtained during the diagnostic, therapeutic, or post-treatment phase of the internal radiation treatment. The internal dosimetry image / data 310 is made available to the EBRT system 100 via the I / O 200, DICOM, or an imaging console.
[0084] The automated adaptive workflow S100 initiates generation of a treatment plan for the EBRT system 100 via the treatment planning system 400 . The treatment planning system 400 includes a patient model generation module 400A for generating a reference patient model 410 , and a treatment plan generation module 400B for generating a reference treatment plan 420 for the reference patient model 410 .
[0085] In a typical planning process, a reference image of the patient is acquired, and a qualified medical staff (physician) manually (or semi-automatically) delineates on the image the malignancy, as well as one or more organs, tissues, etc. susceptible to significant damage from radiation exposure. Typical delineations of malignancies include a gross target volume (GTV), a clinical target volume (CTV), and a planning target volume (PTV).
[0086] In the present case, the reference image may be a CT image acquired during the internal radiation protocol S300 to perform dosimetry in S302. The patient model generation module 400A is configured to automatically determine targets to be irradiated and targets to be avoided directly from the internal dosimetry image / data 310 obtained from the internal radiation protocol S300.
[0087] like Figure 3 and Figure 6 As shown in FIG. 3 , the patient model generation module 400A includes a dose calculation module 402A that applies a dose calculation algorithm to calculate a radiation dose level (e.g., DL1-DL4) for each radiopharmaceutical distribution active region shown in the internal radiation image 310. The dose calculation module 402A also applies a conversion algorithm 402A′ to convert each of the calculated dose levels (DL1-DL4) into targets to be irradiated (e.g., Target 1-Target 3) and targets to be avoided (e.g., OAR1-OAR2).
[0088] The patient model generation module 400A also includes a contouring module 403A, which is configured to automatically generate a target structure (TS) that represents the contours around the target to be irradiated and the target to be avoided on the CT image. The contours generated for the target structure to be irradiated include the gross target volume (GTV) of the tumor, the clinical target volume (CTV) and the planning target volume (PTV). The target to be avoided can also be automatically cropped by an asymmetric margin from the irradiated target for treatment planning.
[0089] The dose calculation and contouring module implements the following software / hardware tools that allow the direct conversion of areas showing radiopharmaceutical distribution activity into: targets; and delineation of targets, including the gross target volume (GTV), clinical target volume (CTV) and planning target volume (PTV) of the tumor to be irradiated; and delineation of targets to be avoided (e.g., OARs).
[0090] The Dose Calculation and Contouring Module also implements a software / hardware tool that allows the use of a reconstructed SPECT / CT or PET / CT post-treatment image set from an internal radiation protocol for radiation dose purposes that represents the delivered dose, and allows the user to define or select a predefined contour via thresholding for use in dosimetry calculations for a local deposition model. The Dose Calculation and Contouring Module can also evaluate radiopharmaceutical dose distributions, generate DVHs and isodose contours.
[0091] One or more anatomical structures of interest (e.g., body contours) and one or more influencer structures (outlines of organs and / or non-volumetric structures that influence one or more of the shape, size, and position of one or more target structures TS in the target structure TS) may also be generated on the reference CT image, such as Figure 7 as shown in .
[0092] Influencers are structures that influence one or more of the shape, size, and position of one or more of the primary target, nodule target, primary organs, and other anatomical structures of interest during online fitting. These influencers can include structures such as organs that typically move on a daily basis and / or exhibit large deformations and / or movements, as well as other non-volumetric structures that describe the anatomical situation, such as, for example, points or 2D lines.
[0093] The target structure (TS) depicted on the reference CT image 410A / 410B can be evaluated by qualified medical personnel (physician) on the computer display 401A using the contour evaluation module 404A. If accepted, the reference image including the target structure / influencer structure / anatomical structure of interest becomes the reference patient model 410. The reference patient model 410 / 410', the reference image (i.e., CT image), the target structure on the reference image (i.e., the reference target structure), and information about the shape and position of the reference image and the reference target structure in the reference image, and information about the influencer, and other depicted anatomical structures are sent to the EBRT system 100 via the I / O 200, DICOM, or imaging console, or made available to the EBRT system 100 via the I / O 200, DICOM, or imaging console.
[0094] In order to generate a treatment plan, a medical staff (physician) generates a list of treatment parameters, such as but not limited to: targets to maximize radiation, targets to minimize radiation, and other parameters and instructions related to the specific EBRT system 100 and imaging device 101 that will deliver the treatment plan to the patient 110. The physician also indicates a preferred dose distribution for the target structure. The dose distribution is expressed as a set or template of clinical goals (CGs), which are suitable targets for the radiation dose of the treatment patient. These clinical goals (CGs) can be given, for example, in the form of an average radiation dose to the target structure (in Gray), and a dose that a certain volume of an organ (such as an organ at risk (OAR)) must not exceed. However, the clinical goals can also be given in other dimensions that are not in the form of radiation dose to the target structure and dose to the organ volume. Each of the given goals can also be prioritized to describe the importance of achieving one goal compared to another goal. This set is called a prioritized set of clinical goals (prioritized CGs). Each clinical goal can be expressed as a quality metric Q and its associated target value. An exemplary prioritized set of clinical goals is:
[0095] Goal 1: The target (PTV) must receive 50 Gy: Priority 1
[0096] Goal 2: Organ at risk X (OARx) must receive less than 25 Gy: Priority 2
[0097] Goal 3: Organ at risk Y (OARy) must receive a mean dose of less than 30 Gy: Priority 3
[0098] exist Fig. 9 and Fig.10 Other exemplary reference clinical target templates are shown in .
[0099] The treatment plan generation module 400B then minimizes the cost function (C ) defining the dose distribution of the prioritized set of clinical goals (CG) through an optimization process. G), to automatically generate an optimized plan (i.e., reference plan 420) for the reference patient module 410. There are many algorithms that can be applied to minimize the cost function, including but not limited to calculating the gradient of the cost function. The solution to the optimization process results in the determination of treatment parameters for the treatment plan candidate 420'. In order to optimize the treatment plan, at the beginning of the treatment planning process, a plurality of control points (CPs) are also specified for the beam trajectory of the beam shaping element of the EBRT system 100 being considered. Each control point (CP) is associated with a set of treatment parameters, which includes but is not limited to a set of (MLC) leaf positions, (MLC) shapes, gantry rotation speed, gantry position, dose rate and / or any other parameters. The number and position of the control points (CPs) can be set in any convenient manner, such as but not limited to, by using treatment planning software or by a system operator. In an exemplary embodiment, the beam trajectory can include a single 180 degree arc trajectory and approximately 177 sequential control points (CPs), which means that there are 177 configurations that the LINAC should conform to in order to deliver the planned treatment. Based on the treatment parameters, a dose distribution within the treatment volume may be calculated for each control point (CP) by any number of techniques, such as but not limited to pencil beam convolution or any other suitable algorithm, and the radiation dose distribution for each (CP) may be associated with the corresponding gantry angle, (MLC) configuration, and monitor unit (MU). In this way, during treatment delivery, the extracted (CP) parameters may be associated with the corresponding calculated dose distribution for each (CP).
[0100] At 403B, the physician may also evaluate the treatment plan candidate 420'. The accepted treatment plan candidate becomes the reference treatment plan 420. The reference treatment plan 420 and associated parameters (i.e., reference clinical target, reference dose specification, reference clinical target value, reference treatment plan 3D dose, how the plan is optimized, reference control points, etc.) are stored in a storage device of the treatment planning system 400 to be later retrieved by the EBRT system 100 for operating the EBRT system 100 to deliver radiation treatment according to the selected radiation treatment plan.
[0101] The physician also develops an adaptive instruction set 230 , which is a list of parameters / instructions / information describing the intent of the adaptive treatment, ie, a 4D description of the planned treatment for the patient 110 . The adaptive indication set may include: information about the planned (reference) dose instructions (i.e., Rx prescription), whether adaptive or standard IGRT treatment is to be used, specified clinical goals (such as, but not limited to, target dose coverage and (OAR) hazard dose limits), planned (reference) clinical target values, planning (reference) images, supporting images (PET, MRI, etc.) with their corresponding registration information, a planned (reference) patient model (i.e., contours of reference structures such as target volume, OARs and other internal dose-derived structures on the reference image), a planned (reference) treatment plan (RT plan), a planned (reference) treatment plan 3D dose (i.e., RT 3D dose), a list of reference structures (target volume, OARs, influencer structures, body shape), a list of influencer structures for different treatment sites, information about the shape and position of the planned (reference) structures on the planned (reference) images, and any information about how the planned (reference) treatment plan is optimized.
[0102] The intent of adaptive radiation therapy is to appropriately modify the radiation treatment plan (i.e., the reference treatment plan 420) to account for temporal changes in the anatomy. Thus, images acquired during a treatment session at a treatment site (i.e., treatment session images 500, such as, for example, CBCT images) are sent to the treatment planning system 400, where the treatment plan can be adapted to the current anatomy via deformable registration software and sent back to the EBRT system 100 for delivery.
[0103] To adapt the reference treatment plan 420, an accurate session patient model 600 (i.e., contours on the current anatomy) is first generated, then the reference treatment plan 420 is appropriately modified to fit the new anatomy and then quickly evaluated for application to the patient 110. The on-couch adaptive workflow 220 generates the session patient model 600 in a step-by-step manner through a series of automated steps guided by the adaptive set of instructions 230. The set of instructions 230 is also used to guide the generation (700) and selection (800) of the treatment plan that best suits the patient's current anatomy.
[0104] A radiation technologist (RTT / MTA) (i.e., user / fitter) who is skilled and trained in reviewing anatomy and plan selection and whose task is to deliver adaptive treatment to the patient performs the first level of treatment modification by positioning the patient on the treatment couch and moving the patient to the imaging position (see Figure 2 ).
[0105] After patient setup, one or more treatment session images (500) of a portion of interest of the patient 110 are acquired using the radiation imaging device 101. In one exemplary embodiment, the treatment session images are, for example, 3D or 4D CBCT scans obtained during a treatment session by irradiating the region of interest of the patient 110 with radiation 120. The treatment session images may show the patient's bone structure but do not include any depiction of a target volume or other structures.
[0106] The RTT / MTA then initiates the generation of contours of the reference structures on the treatment session image 500 via the contouring module 403A to obtain a treatment session patient model 600. This may be accomplished by propagating (601) the reference target structure (TS) from the reference image 410A onto the treatment session image 500 to obtain a treatment session image containing the propagated target structure (602). The RTT / MTA may evaluate the treatment session image thus obtained, and if acceptable, the image becomes the treatment session patient model 610, as shown. Fig.11 and Fig.12 as shown in .
[0107] Alternatively, the RTT / MTA initializes (603) the delineation of the influencers included in the adaptive indication set 230 on the treatment session image 500, and then the RTT / MTA starts (605) the propagation of the reference target structure (TS) included in the reference image 410A'. That is, the RTT / MTA starts the propagation of the target volume (CTV, PTV, etc.), OARs, and other anatomical structures of interest in addition to the influencer structures present in the reference image 410A'. The RTT / MTA can evaluate the obtained treatment session image (606), and if acceptable, the image becomes the treatment session patient model 610', as shown. Fig.13 and Fig.14 as shown in .
[0108] The propagation can be accomplished using a structure-guided deformable registration algorithm (structure-guided DIR) that registers the image data of the reference image 410A / 410A' with the image data 510 of the treatment session image 500, and as a result, generates one or more deformable vector fields (DVFs) that are used to propagate the target volume (CTV, PTV, etc.), OARs, and other anatomical structures of interest from the reference image 410A / 410A' to the treatment session image 500 using the contour propagation module 403A.
[0109] When using influencers, the guided deformable registration is one that is guided by the relationship between the influencer structures present in the reference image 410A′ and the influencer structures generated in the treatment session image 500 .
[0110] To generate different treatment plans 700, the correct treatment isocenter is first determined. Fig.16 As shown in , when the adaptive workflow 220 is started, the patient 110 is set up on the treatment couch 112 in the same manner as a standard radiation therapy treatment. Thus, after positioning the patient 110 on the treatment couch 112, the patient 110 is brought to the isocenter of the EBRT system 100 using traditional skin markings indicating the location of the isocenter.
[0111] When the treatment session image (i.e., for example, CBCT image) 500 is acquired, the center of the treatment session image 500 corresponds to the acquisition isocenter. If the patient 110 is treated by aligning the acquisition isocenter with the system isocenter, the patient 110 will not be treated correctly because Fig.16 As shown in , the session target volume is not aligned with the reference target volume.
[0112] To determine the correct treatment isocenter, once the RTT / MTA accepts the propagated target structure on the treatment session image 500, the EBRT system 100 is prompted at S711 to automatically align the reference target structure / volume of the reference patient model 410 / 410' with the treatment session target structure / volume of the treatment session patient model 610 / 610'.
[0113] like Fig.16 As shown in , the alignment provides the difference between the acquisition isocenter and the reference treatment isocenter. Based on the difference, the translation (X, Y, Z) value is calculated, that is, how much the patient 110 needs to move in the X, Y and Z directions to align the two isocenters. Then, at S712, the calculated translation value is applied to the acquisition isocenter so that the treatment isocenter position is determined. The treatment isocenter position is then provided to the plan generation algorithm 402B, which uses information about the reference treatment plan 420 to generate a scheduled plan 714. The scheduled plan 714 also contains information about the new treatment couch 112 position, which will be transmitted to the EBRT system 100 if the scheduled plan is selected for treatment. When the scheduled treatment plan contains a new treatment couch position, it forces the RTT / MTA to apply (move the treatment couch 112) to the new position.
[0114] To generate an adaptive plan, the propagated treatment session structures (i.e., target structures, OARs) and synthetic (simulated) images of the patient are typically used as input to a plan generation algorithm to optimize a reference plan. Synthetic images are required in order to generate a treatment plan from a stable and reproducible patient position. Generating synthetic images involves a series of steps, including having to register the treatment session images with a reference image including the reference structures, using the result of the registration as input to a deformable registration algorithm, and using the output from the deformable registration algorithm together with data about the body shape from the treatment session images as input to the synthetic image generation algorithm.
[0115] The automated adapted plan generation process described herein does not require synthetic image data as input, and therefore, does not require the additional steps involved when synthetic images must be generated. Instead, the adapted plan generation algorithm uses the propagated treatment session structure (i.e., target structure, OAR) as input to modify the scheduled plan based on the new anatomy 714. This is possible because the reference plan and associated data are derived directly from the internally irradiated CT images.
[0116] like Fig.15 As shown in , the automated plan generation algorithm of S720 takes the propagated treatment session structure (i.e., target structure, OAR) as input to modify the scheduled plan 714 based on the new anatomy. The treatment parameters of the scheduled plan 714 for one or more control points (CPs) can be used to automatically generate an optimized parameter / criteria set in S721, which is used for adaptive plan generation in S713.
[0117] For example, based on the (MLC) configuration of each control point (CP) in the plan 714 for scheduling, the dose distribution of the current plan can be calculated. The calculated dose distribution indicates the actual dose distribution in the target structure and OAR that can be achieved based on the current plan. Since the mapping of the priority value P (i.e., priority 1, priority 2, priority 3, etc.) about the original clinical goal (CG) to the achieved value of the goal (i.e., the actual dose achieved for the goal) gives the plan quality of the goal, the plan quality of the current plan about the original clinical goal (CG) can be determined based on the calculated dose distribution. This can be done by determining the priority value P corresponding to the actual dose value of the goal. In the case where the quality target metric is represented by a quality function (Q function), the P value can be read from the Q function generated for the clinical goal. The larger the value of the priority P of the goal, the better the goal is achieved, and therefore the better the quality of the plan for the goal.
[0118] Therefore, according to the calculated dose distribution of S722, a set of plan quality values P of the current plan can be obtained, one plan quality value P for each original clinical target CG in the original clinical target CG.
[0119] Optionally, for example, in S723, the overall plan quality of the current plan may be obtained according to the individual current plan qualities by taking the minimum value of all individual target quality values.
[0120] Alternatively, the overall plan quality of the current plan may be obtained by defining the overall plan quality as the plan quality that minimizes the difference with the individual plan qualities.
[0121] Based on the value P of the overall quality of the current plan in S723, in S724, a determination may be made as to whether the current plan is acceptable, in which case the current plan becomes an adapted plan 727. In the case where the current plan is unacceptable, the control points used as input to the optimization algorithm in S721 are automatically adjusted via multi-resolution adjustment in S725. Adjusting the control points changes the dose distribution in S722, which then changes the plan quality value of the current plan. The overall plan quality is then calculated again in S723 to determine whether the subsequently obtained plan is acceptable or whether further adjustment of the control points in S725 is required.
[0122] The multi-resolution adjustment in S726 allows for multi-level (eg, four-level) adjustment, from coarse adjustment at level 1 to fine adjustment at level 4. The 4th level adjustment allows for fine tuning of the dose distribution.
[0123] For each iteration of the optimization algorithm, a determination may be made as to whether an individual plan quality value or an overall plan quality value of the current plan is acceptable, for example, by comparing one or more of the calculated quality values with the plan quality value / overall plan quality value of the original treatment plan in S724. If the difference exceeds a predetermined threshold, the result is determined to be unacceptable, in which case the control points (CP) are incrementally modified in S725. The amount of adjustment, and therefore the level of resolution, may be determined based on the calculated difference.
[0124] When accepted, the adapted plan 727 is optimized to have a dose distribution with similar dosimetric properties to the dose distribution of the originally planned treatment plan (i.e., the reference treatment plan 410). Therefore, the adapted plan 727 should achieve the original clinical goals to a similar degree as the original / reference treatment plan 410.
[0125] The reference treatment plan 410, the scheduled treatment plan 714, and the adapted treatment plan 727 may be applied to the dose calculation algorithm of the dose calculation module 402A to calculate the respective radiation doses to be applied to the target structure / volume of the treatment session according to the respective treatment plans. The reference, scheduled, and adapted dose matrices thus generated may be sent to a display device together with the generated reference, scheduled, and adapted plans and the reference, scheduled, and adapted isodose values for display to the RTT / MTA user, such as Figures 17 to 19 , for the user to select 800 an appropriate plan to be delivered to the patient.
[0126] The RTT / MTA is also provided with one or more tools (hardware, software, etc.) to evaluate the scheduled plan and the adapted plan. The tool may include a tool that provides: isodose distribution of the reference plan on the reference image, isodose distribution of the scheduled plan on the treatment session image, isodose distribution of the adapted plan on the session treatment image, and dose volume histograms (DVH) of the reference plan, the scheduled plan, and the adapted plan. The tool may also include a tool for clinical goal evaluation to provide reference clinical goal values and clinical actual values of the scheduled and adapted plans. Optionally, the RTT / MTA may be presented with other images, such as those from internal radiation treatments, which may assist in the plan selection process. The RTT / MTA may choose what information to display and what additional tools to use to help select the most appropriate plan.
[0127] The RTT / MTA uses the reference clinical target and the reference clinical target value in the indication set to quantitatively evaluate whether the scheduled and / or adapted plan is medically necessary for the treatment session of the day (i.e., the current treatment session). To this end, the reference clinical target values and the actual clinical values of the scheduled and adapted treatment plans are presented to the RTT / MTA on a display, and the RTT / MTA selects the treatment plan that provides the clinical value that is closest to the reference clinical target value.
[0128] Once the user selects a treatment plan, radiation treatment will be performed according to the selected plan 900. The prescribing physician or any other qualified physician who generated the original / reference treatment plan 410, adaptive instructions 230, and adaptive workflow 230 may review and / or monitor treatment delivery offline, such as Figure 2 as shown in .
[0129] At 1000, the calculated dose 920 for the delivered radiation plan 910 (i.e., the scheduled treatment plan or the adapted treatment plan, or another other contingency treatment plan created based on the reference plan but for a previously calculated mean target volume position (mean CTV position) that includes a larger dose margin than the dose margin calculated for the reference target volume) may be compared to the reference / planned radiation dose, and if it is not acceptable, an additional treatment protocol 1002 may be contemplated, such as Fig.17 The additional treatment protocol 1002 may be one of another internal radiation protocol, another EBRT protocol, or another treatment protocol determined to be suitable by qualified personnel. Otherwise, the dual-modality radiation protocol ends at 1001.
[0130] Throughout adaptive radiation treatment, plan checks can be validated to ensure delivery on the treatment device using DICOM artifacts (reference plans, images, structures, doses, etc.) provided for independent quality assurance. Optionally, the independent validation application communicates validation results (QA) back to the adaptive workflow application.
[0131] It is therefore apparent that the disclosed subject matter enables the use of internal dosimetry data to generate a reference patient model, and a set of instructions to guide an adaptive workflow to generate a treatment session patient model and to generate and select an appropriate treatment plan for the treatment session.
[0132] It is therefore also apparent that the disclosed subject matter enables a system and method for sequentially exposing a patient to a dual-modality radiation protocol comprising an internal radiation protocol and an external beam radiation protocol as disclosed herein.
[0133] It will be recognized that aspects of the disclosed subject matter may be implemented wholly or partially in hardware, hardware programmed by software, software instructions stored on a computer-readable medium (eg, a non-transitory computer-readable medium), or any combination of the above.
[0134] For example, components of the disclosed subject matter (including components such as controllers, processes, or any other features) may include, but are not limited to, a personal computer or workstation or other such computing system that includes a processor, microprocessor, microcontroller device, or includes control logic that includes an integrated circuit, such as, for example, an application specific integrated circuit (ASIC).
[0135] Features discussed herein can be performed on a single or distributed processor (single core and / or multi-core), by components distributed across multiple computers or systems, or by components co-located in a single processor or system. For example, aspects of the disclosed subject matter can be implemented via: a programmed general purpose computer, an integrated circuit device (e.g., ASIC), a digital signal processor (DSP), an electronic device programmed with microcode (e.g., a microprocessor or microcontroller), a hard-wired electronic or logic circuit, a programmable logic circuit (e.g., a programmable logic device (PLD), a programmable logic array (PLA), a field programmable gate array (FPGA), a programmable array logic (PAL)), software stored on a computer readable medium or signal, an optical computing device, a networked system of electronic and / or optical devices, a special purpose computing device, a semiconductor chip, a software module or object stored on a computer readable medium or signal.
[0136] When implemented in software, the function can be stored on a computer-readable medium or transmitted via a computer-readable medium as one or more instructions or codes on a computer-readable medium. The steps of the method or algorithm disclosed herein can be embodied in a processor executable software module that can reside on a computer-readable medium. Instructions can be compiled from source code instructions provided according to a programming language. Programming instruction sequences and data associated therewith can be stored in a computer-readable medium (e.g., a non-transient computer-readable medium), and the computer-readable medium is such as a computer memory or a storage device, which can be any suitable memory device, such as, but not limited to, a read-only memory (ROM), a programmable read-only memory (PROM), an electrically erasable programmable read-only memory (EEPROM), a random access memory (RAM), a flash memory, a disk drive, etc.
[0137] As used herein, computer-readable media include both computer storage media and communication media, thereby including any medium that is convenient for transferring a computer program from one place to another. Therefore, the storage medium can be any available medium that can be accessed by a computer. By way of example, and not limitation, such computer-readable media can include RAM, ROM, EEPROM, CD-ROM or other optical disk storage devices, magnetic disk storage devices or other magnetic storage devices, or can be used to carry or store the desired program code in the form of instructions or data structures and any other medium that can be accessed by a computer.
[0138] Moreover, any connection is properly termed a computer-readable medium. For example, if the software is transmitted from a website, server or other remote source using a transmission medium (e.g., a coaxial cable, fiber optic cable, twisted pair, digital subscriber line (DSL), or wireless technologies such as infrared, radio and microwave), the transmission medium is included in the definition of computer-readable medium. In addition, the operations of a method or algorithm may reside as one of (or any combination of) a set of codes and / or instructions on a machine-readable medium and / or a computer-readable medium, which may be incorporated into a computer program product.
[0139] Those of ordinary skill in the art will readily appreciate that the above description is not exhaustive, and aspects of the disclosed subject matter may be implemented in ways other than those specifically disclosed above. In fact, embodiments of the disclosed subject matter may be implemented in hardware and / or software using any known or later developed system, structure, device, and / or software by those of ordinary skill in the applicable field in accordance with the functional description provided herein.
[0140] In this application, unless specifically stated otherwise, the use of the singular includes the plural, and the individual use of "or" and "and" includes the other, i.e., "and / or." In addition, the use of the terms "include" or "have" and other forms such as "include," "comprising," "having," or "having" are intended to have the same effect as "comprising," and therefore should not be construed as limiting.
[0141] Any range described herein will be understood to include the endpoints and all values between the endpoints. Unless expressly stated otherwise, whenever "substantially," "about," "essentially," "close to," or similar language is used in combination with a particular value, it is intended to be up to and including a 10% variation of that value.
[0142] The terms "system," "device," and "module" are used interchangeably herein, and the use of one term in the description of an embodiment does not preclude the application of the other terms to that or any other embodiments.
[0143] The present disclosure enables many substitutions, modifications and variations. Although specific examples are shown and described in detail for the purpose of illustrating the application of the principles of the present invention, it will be appreciated that the present invention may be embodied in other ways without departing from such principles. For example, the disclosed features may be combined, rearranged, omitted, etc. to produce additional embodiments, and certain disclosed features may sometimes be advantageously used without the corresponding use of other features. Therefore, the applicant intends to encompass all such substitutions, modifications, equivalents and variations within the spirit and scope of the present invention.
Claims
1. A radiation treatment method, include: Exposing the patient to a dual-modality radiation protocol comprising: Internal radiation protocols; and External beam radiation protocol, The internal radiation protocol includes: administering a radiopharmaceutical to the patient; and generating a dosimetry image of the distribution of radiopharmaceutical activity in the patient; and The external beam radiation protocol includes implementing an automated workflow to: generating a radiation treatment plan based on data from the dosimetry image; adapting the radiation treatment plan to a current treatment session using the set of instructions; and An adapted treatment plan is delivered to the patient. 2 . The method according to claim 1 , wherein the internal radiation protocol is a protocol included in one of the following: radiological systemic therapy, radioembolization radiation treatment, chemotherapy, immunotherapy or targeted radiation therapy. 3 . The method of claim 1 , wherein the external beam radiation protocol is a couch-based adaptive radiation therapy protocol and the automated workflow is an automated adaptive workflow. 4 . The method of claim 1 , wherein the dosimetry image is a diagnostic dosimetry image, a treatment dosimetry image, or a post-treatment dosimetry image. The method according to claim 4 , wherein the dosimetry image is a SPECT / CT or PET / CT reconstructed image. The method of claim 1 , wherein the dosimetry image is an absorbed dose map.
7. The method of claim 1, wherein the radiation treatment plan is generated include: generating a reference patient model using the dosimetry image; as well as selecting a set of planned clinical objectives for the reference patient model as input to a plan generation and optimization algorithm, The plan generation and optimization algorithm derives objectives for the planned clinical goals and generates a reference treatment plan that meets the derived objectives.
8. The method of claim 7, wherein the reference patient model is generated include: calculating absorbed radiation dose from data of the dosimetry image; converting the absorbed radiation dose into targets to be irradiated and targets to be avoided; as well as applying an automated contouring process to generate a target structure on a reference image, the target structure representing contours of the target to be irradiated and contours of the target to be avoided, The reference image is an image used in obtaining the dosimetry image.
9. The method of claim 8, wherein the automated contouring process also generates influencer structures representing contours of one or more organs that influence one or more of the shape, size, or position of one or more of the target structures.
10. The method of claim 7, wherein the target structures include one or more contours of a primary tumor and one or more contours of organs at risk (OARs).
11. The method of claim 10, wherein the clinical goal is expressed as a radiation dose for target structures and a radiation dose for OARs that must not be exceeded.
12. The method of claim 10, wherein the clinical goal is expressed as a quality metric and an associated target value.
13. The method of claim 7, wherein the radiation treatment plan is adapted to a current treatment session include: Using the set of instructions, a series of automated steps are performed to: generating a treatment session patient model; generating a first treatment plan and a second treatment plan for the session patient model; as well as A treatment plan appropriate for the current treatment session is selected.
14. The method of claim 13, wherein the set of instructions comprises information about planned radiation doses, planned clinical goals, planned clinical goal values, reference patient models, reference treatment plans, reference plan quality values, influencer structure lists, and control points.
15. The method of claim 13, wherein the treatment session patient model is generated include: generating a treatment session image of a portion of the patient including anatomy of interest; as well as The target structure of the reference image is propagated to the treatment session image.
16. The method of claim 15, wherein the propagation of the target structure is directed by one or more influencer structures from the list of influencer structures. The method of claim 15 , wherein the treatment session images are CBCT images.
18. The method of claim 14, wherein generating a first treatment plan include: obtaining a reference isocenter position of the reference patient model from the set of indications; determining an acquisition isocenter location of a patient model of the treatment session; aligning the target structure in the treatment session patient model with a corresponding reference target structure in the reference patient model; determining a difference between the reference isocenter position and the acquisition isocenter position; determining a treatment session isocenter position by applying the determined difference to the acquisition isocenter position; as well as The treatment session isocenter location is used as input to the plan generation and optimization algorithm to generate the first treatment plan.
19. The method of claim 18, wherein generating the second treatment plan include: using the first treatment plan as input to the treatment plan generation and optimization algorithm to generate a current plan, wherein the plan generation and optimization algorithm includes optimization parameters automatically generated based on control points of the first treatment plan; as well as The second treatment plan is generated by optimizing the current plan based on the plan quality value of the first treatment plan.
20. The method of claim 19, wherein the first treatment plan is a scheduled treatment plan and the second treatment plan is an adapted treatment plan.
21. The method according to claim 20, further comprising: include: comparing the first treatment plan and the second treatment plan with the reference treatment plan; selecting a treatment plan suitable for the current treatment session; as well as Deliver the selected treatment plan.
22. The method according to claim 20, further comprising: include: Calculate planned dose accumulation and delivered dose accumulation; as well as An additional treatment protocol is determined based on the comparison results.
23. The method of claim 22, wherein the further treatment protocol is a further internal radiation protocol or a further external beam radiation protocol.
24. A method for generating a treatment plan for external beam radiation therapy, include: obtaining dosimetric SPECT / CT or PET / CT images from an internal radiation treatment system indicating radiopharmaceutical uptake in the patient; automatically converting the radiopharmaceutical uptake into targets to be irradiated and targets to be avoided; applying an automated contouring process to generate target structures on a reference image, the target structures representing contours of the targets to be irradiated and contours of the targets to be avoided, the reference image being a CT image used to obtain the dosimetric SPECT / CT or PET / CT image; as well as A set of planned clinical goals is selected for the target structure as input to a plan generation and optimization algorithm to automatically derive objectives for the planned clinical goals and generate a reference treatment plan that meets the derived objectives.
25. The method of claim 24, wherein the target structures include one or more contours of a primary tumor and one or more contours of organs at risk (OARs).
26. The method of claim 25, wherein the clinical goal is expressed as a quality metric and an associated target value.
27. The method of claim 26, further comprising adapting the radiation treatment plan to a current treatment session.
28. The method of claim 27, wherein the adapting comprises using a set of instructions to perform a series of automated steps to: generating a treatment session patient model; generating a first treatment plan and a second treatment plan for the session patient model; and A treatment plan appropriate for the current treatment session is selected.
29. The method of claim 28, wherein the set of instructions comprises information on planned radiation doses, planned clinical goals, planned clinical goal values, reference patient models, reference treatment plans, reference plan quality values, control points, and influencer lists.
30. The method of claim 28, wherein the treatment session patient model is generated include: generating a treatment session image of a portion of the patient including anatomy of interest; as well as The target structure of the reference image is propagated to the treatment session image.
31. The method of claim 30, wherein propagation of the target structure is directed by one or more influencers from the list of influencers.
32. The method of claim 30, wherein generating a first treatment plan include: obtaining a reference isocenter position of the reference patient model from the set of indications; determining an acquisition isocenter location of a patient model of the treatment session; aligning the target structure in the treatment session patient model with a corresponding reference target structure in the reference patient model; determining a difference between the reference isocenter position and the acquisition isocenter position; determining a treatment session isocenter position by applying the determined difference to the acquisition isocenter position; as well as The treatment session isocenter location is used as input to the plan generation and optimization algorithm to generate the first treatment plan.
33. The method of claim 32, wherein the second treatment plan is generated include: using the first treatment plan as input to the treatment plan generation and optimization algorithm to generate a current plan, wherein the plan generation and optimization algorithm includes optimization parameters automatically generated based on control points of the first treatment plan; as well as The second treatment plan is generated by optimizing the current plan based on the plan quality value of the first treatment plan.
34. A system for automating a workflow for an adaptive radiation therapy session for a patient, include: A computer processing system configured to: obtaining an indication set comprising information representing a planned treatment plan for the patient; as well as Using the set of instructions, a series of automated steps are performed to: generating a treatment session patient model; as well as generating an adapted treatment plan for the treatment session patient model, Wherein the planned treatment plan is generated based on dosimetry image data obtained during an internal radiation treatment protocol, the dosimetry image data being indicative of radiopharmaceutical uptake in the patient.
35. The system of claim 34, further comprising a treatment planning system, the treatment planning system include: The patient model generation module is configured as follows: automatically converting the radiopharmaceutical uptake into targets to be irradiated and targets to be avoided; as well as applying an automated contouring process to generate a target structure on an image used to generate said dosimetry image data, said target structure representing contours of said target to be irradiated and contours of said target to be avoided; as well as The treatment plan generation and optimization module is configured to: allowing selection of a clinical target for the target structure from a clinical target template; Derive objectives for selected clinical goals; as well as A reference treatment plan is generated that satisfies the derived purpose.
36. A system according to claim 35, wherein the indication set includes information about the following: a planned radiation dose, a planned clinical goal, a planned clinical goal value, a reference patient model, a reference treatment plan, a list of influencer structures, one or more reference images, control points, and a list of influencers including anatomical structures that have an impact on other anatomical structures of the patient.
